Cargando…

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis

OBJECTIVES: To describe characteristics and outcomes of patients with small cell neuroendocrine carcinoma of the cervix (SCNCC) and determine the staging system most predictive of outcome—the two-tier (limited-stage [LS] vs. extensive-stage [ES]) or International Federation of Gynecology and Obstetr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordhandas, Sushmita, Schlappe, Brooke A., Zhou, Qin, Iasonos, Alexia, Leitao, Mario M., Park, Kay J., de Brot, Louise, Alektiar, Kaled M., Sabbatini, Paul J., Aghajanian, Carol A., Friedman, Claire, Zivanovic, Oliver, O'Cearbhaill, Roisin E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365998/ https://www.ncbi.nlm.nih.gov/pubmed/35967833 http://dx.doi.org/10.1016/j.gore.2022.101058

Ejemplares similares

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
por: Kyi, Chrisann, et al.
Publicado: (2021)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study
por: Oseledchyk, Anton, et al.
Publicado: (2018)

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
por: Teckie, Sewit, et al.
Publicado: (2013)

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
por: Boland, Julia L., et al.
Publicado: (2018)

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
por: O’Cearbhaill, Roisin E., et al.
Publicado: (2016)

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
por: Friedman, Claire F., et al.
Publicado: (2023)

Primary osteosarcoma of the uterus with cardiac and pulmonary metastases
por: Abraham, Cynthia, et al.
Publicado: (2014)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
por: Crowley, Fionnuala, et al.
Publicado: (2022)

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
por: Rubinstein, Maria M., et al.
Publicado: (2023)

Quaternary and beyond cytoreduction: An updated and expanded analysis
por: Manning-Geist, Beryl L., et al.
Publicado: (2021)

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
por: Zamarin, Dmitriy, et al.
Publicado: (2020)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia
por: Freites-Martinez, Azael, et al.
Publicado: (2022)

Comparative genomics of high grade neuroendocrine carcinoma of the cervix
por: Hillman, R. Tyler, et al.
Publicado: (2020)

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission
por: Manning-Geist, Beryl L., et al.
Publicado: (2023)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer
por: Miller, Kathryn M., et al.
Publicado: (2021)

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines
por: Praiss, Aaron, et al.
Publicado: (2022)

Large-cell neuroendocrine carcinoma of the cervix
por: Yoseph, Benyam, et al.
Publicado: (2012)

Neuroendocrine carcinoma of cervix and review literature
por: Verma, Saransh, et al.
Publicado: (2023)

Leptomeningeal metastasis from neuroendocrine carcinoma of the cervix: illustrative case
por: Patterson, John D., et al.
Publicado: (2023)

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()
por: Schiavone, Maria B., et al.
Publicado: (2016)

Neuroendocrine Carcinoma of Cervix: A Case Series
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer
por: Navitski, Anastasia, et al.
Publicado: (2021)

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
por: Gordhandas, Sushmita B., et al.
Publicado: (2022)

Neuroendocrine carcinoma of the cervix: a systematic review of the literature
por: Tempfer, Clemens B., et al.
Publicado: (2018)

A Nomogram Model Based on Neuroendocrine Markers for Predicting the Prognosis of Neuroendocrine Carcinoma of Cervix
por: Jia, Mingzhu, et al.
Publicado: (2023)

Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
por: Martin, J., et al.
Publicado: (2023)

Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study
por: Manning-Geist, Beryl L., et al.
Publicado: (2022)

Neuroendocrine small cell carcinoma of the cervix: A case report
por: Giordano, Giovanna, et al.
Publicado: (2021)

Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix
por: Bos, Lia, et al.
Publicado: (2021)

Recurrent Neuroendocrine Tumor of the Cervix Presenting With Ectopic Cushing’s Syndrome
por: Rico, Jeffrey G, et al.
Publicado: (2022)

Isolated Central Nervous System Metastasis From Neuroendocrine Carcinoma of the Cervix Without Pulmonary Metastasis
por: Valenzuela, Fabiola, et al.
Publicado: (2020)

Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis
por: Huang, Rui, et al.
Publicado: (2020)

Amphricrine carcinoma of the cervix-adeno neuroendocrine tumor: A case report
por: Fadıloğlu, Erdem, et al.
Publicado: (2016)

Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix
por: Cimic, Adela, et al.
Publicado: (2021)

Ectopic insulin secretion by a large‐cell neuroendocrine carcinoma of the cervix
por: Wang, Mawson, et al.
Publicado: (2020)

Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix
por: Chen, Jian, et al.
Publicado: (2023)

Neuroendocrine carcinoma of the cervix: About a rare case and literature review
por: El Abbassi, Imane, et al.
Publicado: (2023)

A Rare Presentation of Stage IV Large Cell Neuroendocrine Carcinoma of the Cervix with Metastasis to the Cranium
por: Hooker, Neema, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9qnpab579ad8gt2v4k2acvdn2g